Egypts Anti-Obesity drug market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Obesity refers to a medical condition when excessive accumulation and storage of fats tends to happen within the body. The condition impacts the health of an individual in several ways such as it may increase the risks of chronic diseases declining the life expectancy of individuals. Various diets, devices, and drugs are utilized with the purpose of controlling or reducing weight in obese individuals in these management programs.

Obesity in Egypt is not just a disease but a risk factor for other diseases. Prominent prevalence of stigma affects peoples treatment-seeking behavior. People living in the urban areas seek treatment as obesity has a huge stigma attached in these areas. Further, the availability of treatment is better for children and adolescents. Growing awareness seeks to avoid endocrinological complications in children due to obesity and therefore children under 5 years have the greatest support for treatment. This gradually decreases and becomes almost unavailable for those above 18 years of age.



Market Drivers

Diabetes and obesity are MENA's biggest epidemiological challenge. The rapid societal transition to a more urbanized lifestyle with little exercise and westernized diets has caused a huge increase in obesity, which in turn has seen huge increases in diabetes mellitus rates.

The increase in prevalence of chronic diseases such ashypertension, diabetes caused by the rise in adoption of unhealthy and sedentary lifestyle patterns and surge in the number of bariatric surgeries accelerate this weight loss and obesity management market growth. The increase in preference for junk food, physical inactivity, and hectic routine, and the growing stress are causing people to consume fast food further influencing the weight loss and obesity management market.

Limited infrastructure restrains the market growth. However, awareness is increasing, and a greater number of people are now open to seeking treatment. This will bring the market down to affordable drugs and propel the anti-obesity market forward.